Friday, April 28, 2017


Mashable: Soylent Needs A Rebrand, Fast
Los Angeles-based Soylent, which is developing alternative nutrition products aimed at eliminating the need to eat normal food--and which is a favorite of techies and gamers--is in desperate need of a rebrand, according to Mashable. The call for a rebrand comes as the company faces yet another recall on its products, this one a major safety recall involving accidental inclusion of whey in what should be a dairy-free product--a potentially life threatening issue for those allergic to dairy produc (More info...)
posted on Friday, April 28, 2017(Full story)

Work Today Finds $1.1M For Labor Marketplace
Santa Monica-based Work Today, a startup that has launched an online, labor marketplace targeted at blue collar workers, has raised $1.1M in a seed funding round, the company is announcing this morning. The funding came from Mucker Capital, Social Capital, Hone Capital (formerly CSC Venture Capital), E-Merge, and GAN Ventures. Work Today is led by Joe Nigro, who previously had been at HomeHero and Handy. According to Work Today, it is emerging from beta mode with the announcement of the funding. (More info...)
posted on Friday, April 28, 2017 (More)(Full story)

Qualcomm Expects Hit In Earnings From Issues With Apple
San Diego-based Qualcomm says that Apple is continuing to "improperly interfere" with its business, saying that Apple has been withholding payments to its contract manufacturers for royalties those manufacturers owe to Qualcomm, and has indicated that it will continue to do so until it resolves its dispute with Qualcomm. As a result of that action, Qualcomm revised its Q3 FY17 Estimates down from an earlier $5.3 billion to $6.1 billion in revenues, to a new estimate of $4.8 billion to $5.6 billi (More info...)
posted on Friday, April 28, 2017(Full story)

Epic Sciences Raises $40M In Series D Funding
San Diego-based Epic Sciences has raised $40M in a Series D funding, for its cancer testing technology, the company announced Friday morning. According to Epic Sciences, the funding was led by Hermed Capital, and also included Altos Capital Partners, Domain Associates, Genomic Health, Pagoda Investment, Reach Tone Limited, RMI Partners, Sabby Capital and VI Ventures. Epic sciences is developing blood-based tests which help predict drug response in cancer. The company said the fund will go to acc (More info...)
posted on Friday, April 28, 2017 (More)(Full story)